These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9629465)

  • 1. Exploration of the importance of the P2-P3-NHCO-moiety in a potent di- or tripeptide inhibitor of calpain I: insights into the development of nonpeptidic inhibitors of calpain I.
    Chatterjee S; Iqbal M; Mallya S; Senadhi SE; O'Kane TM; McKenna BA; Bozyczko-Coyne D; Kauer JC; Siman R; Mallamo JP
    Bioorg Med Chem; 1998 May; 6(5):509-22. PubMed ID: 9629465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain I.
    Chatterjee S; Ator MA; Bozyczko-Coyne D; Josef K; Wells G; Tripathy R; Iqbal M; Bihovsky R; Senadhi SE; Mallya S; O'Kane TM; McKenna BA; Siman R; Mallamo JP
    J Med Chem; 1997 Nov; 40(23):3820-8. PubMed ID: 9371247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain inhibitors based on the quiescent affinity label concept: high rates of calpain inactivation with leaving groups derived from N-hydroxy peptide coupling reagents.
    Tripathy R; Ator MA; Mallamo JP
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2315-9. PubMed ID: 11055346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally constrained inhibitors of caspase-1 (interleukin-1 beta converting enzyme) and of the human CED-3 homologue caspase-3 (CPP32, apopain).
    Karanewsky DS; Bai X; Linton SD; Krebs JF; Wu J; Pham B; Tomaselli KJ
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2757-62. PubMed ID: 9873617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel piperidine carboxamide derived calpain inhibitors.
    Lubisch W; Hofmann HP; Treiber HJ; Möller A
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2187-91. PubMed ID: 11012026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
    Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
    J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New m-calpain substrate-based azapeptide inhibitors.
    Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
    J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent peptide alpha-ketohydroxamate inhibitors of recombinant human calpain I.
    Josef KA; Kauer FW; Bihovsky R
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2615-7. PubMed ID: 11551762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of 4-aryl-4-oxobutanoic acid amides as calpain inhibitors.
    Zhang Y; Jung SY; Jin C; Kim ND; Gong P; Lee YS
    Bioorg Med Chem Lett; 2009 Jan; 19(2):502-7. PubMed ID: 19041242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of calpain-specific inactivators by screening of positional scanning epoxide libraries.
    Cuerrier D; Moldoveanu T; Campbell RL; Kelly J; Yoruk B; Verhelst SHL; Greenbaum D; Bogyo M; Davies PL
    J Biol Chem; 2007 Mar; 282(13):9600-9611. PubMed ID: 17218315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cell-penetrating alpha-keto-amide calpain inhibitors as potential treatment for muscular dystrophy.
    Lescop C; Herzner H; Siendt H; Bolliger R; Henneböhle M; Weyermann P; Briguet A; Courdier-Fruh I; Erb M; Foster M; Meier T; Magyar JP; von Sprecher A
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5176-81. PubMed ID: 16185867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.
    Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST
    J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
    Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
    J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.
    Donkor IO; Korukonda R; Huang TL; LeCour L
    Bioorg Med Chem Lett; 2003 Mar; 13(5):783-4. PubMed ID: 12617890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivatives of 3-sec-butyl-1-oxo-2,3-dihydroisoquinoline as inhibitors of mu-calpain.
    Chicharro R; Alonso M; Mazo MT; Arán VJ; Herradón B
    ChemMedChem; 2006 Jul; 1(7):710-4. PubMed ID: 16902923
    [No Abstract]   [Full Text] [Related]  

  • 16. A survey of calpain inhibitors.
    Donkor IO
    Curr Med Chem; 2000 Dec; 7(12):1171-88. PubMed ID: 11032966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the potent calpain inhibitory activity of peptidyl alpha-ketoacids.
    Donkor IO; Assefa H; Liu J
    J Med Chem; 2008 Jul; 51(14):4346-50. PubMed ID: 18636690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tripeptide analogues of MG132 as protease inhibitors.
    Pehere AD; Nguyen S; Garlick SK; Wilson DW; Hudson I; Sykes MJ; Morton JD; Abell AD
    Bioorg Med Chem; 2019 Jan; 27(2):436-441. PubMed ID: 30581047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of orally available calpain inhibitors: peptidyl alpha-ketoamides containing an amphiphile at P3 site.
    Shirasaki Y; Miyashita H; Yamaguchi M; Inoue J; Nakamura M
    Bioorg Med Chem; 2005 Jul; 13(14):4473-84. PubMed ID: 15921914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides containing acylated C-terminal gem diamines: novel irreversible inactivators of the cysteine and serine proteinases.
    Gilmore BF; Lynas JF; Harriott P; Healy A; Walker B
    Chem Biol Drug Des; 2006 May; 67(5):364-9. PubMed ID: 16784461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.